secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catalent, Inc. (—)
CIK:        0001596783
Form:       8-K
Filed at:   2023-12-19T23:59:59+00:00
Accession:  0001193125-23-298631
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalent closes $600M incremental term loan upsized due to strong demand; total liquidity ~$1.3B
--------------------------------------------------------------------------------

- Catalent Pharma Solutions borrowed $600M in new term loans under existing credit agreement; upsized due to strong lender demand.
- Proceeds used to repay a portion of outstanding revolver borrowings and pay related fees and expenses.
- Interest rate: Term SOFR + 3.00% (floor 0.50%) or base rate + 2.00%; subject to prepayment premium and step-up.
- Total liquidity post-transaction approximately $1.3 billion, per CFO Matti Masanovich.
- Loans amortize at 1% per annum quarterly starting second full fiscal quarter after closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1596783/000119312523298631/0001193125-23-298631-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1596783/000119312523298631/d676870d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-298631

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer